CAS 87549-36-8

Parcetasal

Description:

Parcetasal, identified by the CAS number 87549-36-8, is a chemical compound that belongs to the class of analgesics and antipyretics. It is primarily used for its pain-relieving and fever-reducing properties. The substance exhibits a mechanism of action similar to that of non-steroidal anti-inflammatory drugs (NSAIDs), although its specific pharmacological profile may differ. Parcetasal is typically characterized by its solubility in organic solvents and limited solubility in water, which can influence its formulation in pharmaceutical products. The compound is often evaluated for its safety and efficacy in clinical settings, with attention to potential side effects and interactions with other medications. As with many pharmaceuticals, proper dosage and administration are crucial for maximizing therapeutic benefits while minimizing adverse effects. Research into Parcetasal may also explore its metabolic pathways and the potential for developing derivatives with improved properties. Always consult relevant scientific literature or databases for the most current and detailed information regarding this compound.

Formula: C₁₇H₁₅NO₅

InChI: InChI=1/C17H15NO5/c1-11(19)18-12-7-9-13(10-8-12)21-17(2)22-15-6-4-3-5-14(15)16(20)23-17/h3-10H,1-2H3,(H,18,19)

SMILES: CC(=Nc1ccc(cc1)OC1(C)Oc2ccccc2C(=O)O1)O

Synonyms:

• Parcetasal [INN]
• Mr 897
• (+-)-4'-((2-Methyl-4-oxo-1,3-benzodioxan-2-yl)oxy)acetanilide
• Parcetasalum
• Parcetasalum [INN-Latin]
• Unii-3Lsz7869T2
• Acetamide, N-(4-((2-methyl-4-oxo-4H-1,3-benzadioxin-2-yl)oxy)-phenyl)-
• N-{4-[(2-methyl-4-oxo-4H-1,3-benzodioxin-2-yl)oxy]phenyl}acetamide

Parcetasal

CAS: 87549-36-8

Formula: C₁₇H₁₅NO₅

Purity: 95%

Color and Shape: Solid

Molecular weight: 313.3047

Ref: IN-DA01E5MA

Parcetasal

CAS: 87549-36-8

Parcetasal

Purity: ≥98%

Molecular weight: 313.3g/mol

Ref: 54-BUP15239

Parcetasal

CAS: 87549-36-8

Parcetasal (MR-897) is a non-steroidal anti-inflammatory agent that can be used in pain relief studies.

Formula: C₁₇H₁₅NO₅

Purity: 99.07%

Color and Shape: Solid

Molecular weight: 313.3

Ref: TM-T12361

Parcetasal

Controlled Product

CAS: 87549-36-8

Applications Parcetasal is a cyclic ester between Acetylsalicylic Acid (A187780) and Paracetamol (A161220), and by enzymatic hydrolysis it is broken down into acetylsalicylic acid, salicylic acid and paracetamol metabolites.
References Marzo, A., et al.: Arzneimittelforschung, 40, 813 (1990);

Formula: C₁₇H₁₅NO₅

Color and Shape: Neat

Molecular weight: 313.305

Ref: TR-P193290

Parcetasal

CAS: 87549-36-8

Parcetasal is an indirubin analog that inhibits the oxidative phosphorylation of cancer cells. It has been shown to inhibit the proliferation and growth of cancer stem cells in a mouse model. Parcetasal has also been reported to inhibit the production of fatty acids, which may be due to its ability to inhibit metabolic disorders such as hepatitis. The drug is currently used for the treatment of various cancers, including non-small-cell lung cancer and prostate cancer. Parcetasal can also be used for the treatment of hyperproliferative diseases such as psoriasis and myeloma.

Formula: C₁₇H₁₅NO₅

Purity: Min. 95%

Molecular weight: 313.3 g/mol

Ref: 3D-MDA54936